SARS-CoV-2-IN-46 is a novel coronavirus (SARS-CoV-2) replication inhibitor with an EC50 of 0.9 µM in Calu-3 cells. SARS-CoV-2-IN-46 has antiviral activity and can be used in novel coronavirus (COVID-19) research[1].
Molecular Weight:
318.27
Purity:
99.77
Formula:
C17H12F2O4
Target:
SARS-CoV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted